Bode U - Search Results

1

[Cyanotic Raynaud phenomenon as a side effect of Amphotericin B].

Zernikow B, Fleischack G, Hasan C, Bode U. Zernikow B, et al. Among authors: bode u. Klin Padiatr. 1996 Mar-Apr;208(2):53-5. doi: 10.1055/s-2008-1043994. Klin Padiatr. 1996. PMID: 8901182 German.

2

Cyanotic Raynaud's phenomenon with conventional but not with liposomal amphotericin B: three case reports.

Zernikow B, Fleischhack G, Hasan C, Bode U. Zernikow B, et al. Among authors: bode u. Mycoses. 1997 Dec;40(9-10):359-61. doi: 10.1111/j.1439-0507.1997.tb00250.x. Mycoses. 1997. PMID: 9470422

3

[IDA-FLAG (idarubicin, fludarabine, high dosage cytarabine and G-CSF)--an effective therapy regimen in treatment of recurrent acute myelocytic leukemia in children and adolescents. Initial results of a pilot study].

Fleischhack G, Graf N, Hasan C, Ackermann M, Breu H, Zernikow B, Bode U. Fleischhack G, et al. Among authors: bode u. Klin Padiatr. 1996 Jul-Aug;208(4):229-35. doi: 10.1055/s-2008-1046478. Klin Padiatr. 1996. PMID: 8926688 German.

4

[High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].

Fleischhack G, Pöpping K, Hasan C, Utsch B, Jüttner J, Bode U. Fleischhack G, et al. Among authors: bode u. Klin Padiatr. 1998 Jul-Aug;210(4):248-55. doi: 10.1055/s-2008-1043887. Klin Padiatr. 1998. PMID: 9743961 German.

5

Pancreatic toxicity after liposomal amphotericin B.

Stuecklin-Utsch A, Hasan C, Bode U, Fleischhack G. Stuecklin-Utsch A, et al. Among authors: bode u. Mycoses. 2002 Jun;45(5-6):170-3. doi: 10.1046/j.1439-0507.2002.00744.x. Mycoses. 2002. PMID: 12100534

6

Recancostat compositum therapy does not prevent tumor progression in young cancer patients.

Bode U, Hasan C, Hülsmann B, Fleischhack G. Bode U, et al. Klin Padiatr. 1999 Jul-Aug;211(4):353-5. doi: 10.1055/s-2008-1043813. Klin Padiatr. 1999. PMID: 10472575 Clinical Trial.

7

Accidental iatrogenic intoxications by cytotoxic drugs: error analysis and practical preventive strategies.

Zernikow B, Michel E, Fleischhack G, Bode U. Zernikow B, et al. Among authors: bode u. Drug Saf. 1999 Jul;21(1):57-74. doi: 10.2165/00002018-199921010-00005. Drug Saf. 1999. PMID: 10433353

8

Nephrotic syndrome as paraneoplastic syndrome of Hodgkin disease.

Utsch B, Fleischhack G, Hasan C, Bode U. Utsch B, et al. Among authors: bode u. Eur J Pediatr. 1999 Sep;158(9):768. doi: 10.1007/s004310051200. Eur J Pediatr. 1999. PMID: 10485316 No abstract available.

9

Acute liver disease and aplastic anemia associated with the persistence of B19 DNA in liver and bone marrow.

Dame C, Hasan C, Bode U, Eis-Hübinger AM. Dame C, et al. Among authors: bode u. Pediatr Pathol Mol Med. 2002 Jan-Feb;21(1):25-9. doi: 10.1080/pdp.21.1.25.29. Pediatr Pathol Mol Med. 2002. PMID: 11842976

10

Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure.

Buchen S, Ngampolo D, Melton RG, Hasan C, Zoubek A, Henze G, Bode U, Fleischhack G. Buchen S, et al. Among authors: bode u. Br J Cancer. 2005 Feb 14;92(3):480-7. doi: 10.1038/sj.bjc.6602337. Br J Cancer. 2005. PMID: 15668713 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters